Primary mesenteric liposarcoma is a rare and highly aggressive tumor that can recur rapidly and multifocally despite complete surgical resection and adjuvant chemotherapy.
Answers are grounded in this paper and cite their sources.
Rapid multifocal recurrence despite resection and chemotherapy signals poor prognosis in mesenteric liposarcoma; leaves open optimal management for this rare entity.
Liposarcoma occurring in the mesentery primarily is a rare entity, scarcely reported in world literature. Here, we report one such case that recurred thrice in spite of complete resection and adjuvant therapy. A literature review on the management of such an aggressive tumor is also outlined. DOI: http://dx.doi.org/10.3126/mjsbh.v10i2.6460 Medical Journal of Shree Birendra Hospital July-Dec 2011 10(2) 29-31
No takes yet. Share an insight, caveat, or question.
Malla et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: